The Children Leukemia Group: 30 Years of research and achievements

European Journal of Cancer

Volumn 38, Issue SUPPL. 4, 2002, Pages 44-49

  Otten, J ^a   Philippe, N ^b   Suciu, S ^c   Béhar, C ^d   Babin Boilletot, A ^e   Thyss, A ^f   Ferster, A ^g   Vilmer, E ^h  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b HÔPITAL DEBROUSSE   (France)

^c EORTC DATA CENTER   (Belgium)

^d AMERICAN HOSPITAL OF PARIS   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f CENTRE ANTOINE LACASSAGNE   (France)

^g HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^h HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Children; EORTC; Leukaemia; Lymphoma; Review

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CARMUSTINE; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; GLUCOCORTICOID; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE MYELOBLASTIC LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; IMMUNOTHERAPY; LEUKEMIA; LYMPHOBLASTOMA; META ANALYSIS; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036177921     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00449-x     Document Type: Review

References (13)

1. Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults (EORTC Protocol 58741)
2. Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia. A report form the BFM study group
3. Treatment of acute lymphoblastic leukemia (ALL) with the BFM protocol: A cooperative pilot study
4. Treatment of acute lymphoblastic leukemia (ALL) with the BFM protocol: A cooperative study and analysis of prognostic factors
5. Long term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: A CLCG-EORTC report
6. Comparison of E. Coli-Asparaginase with Erwinia-Asparaginase in the treatment of childhood lymphoid malignancies. Results of an EORTC-CLG phase III randomized trial
7. Treatment of Cancer (EORTC). Value of high dose cytosine arabinoside during interval therapy of a BFM-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the EORTC 58881 randomized phase III trial
8. The value of 6-MP i.v. during maintenance treatment in childhood acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL): Results of the randomized phase III trial 58881 of EORTC Childhood Leukemia Cooperative Group (CLCG)
9. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
10. Systemic effect of intrathecal methotrexate during the initial phase of childhood acute lymphoblastic leukemia
11. Improved survival for acute lymphoblastic leukemia in infancy: The experience of the EORTC Childhood Leukemia Cooperative Group
12. Treatment outcome in infant acute lymphoblastic leukemia - Letter
13. Mitoxantrone and high dose ARA-C for the treatment of ANLL in childhood: A pilot study of the EORTC CLCG (EORTC 58872)